Patents by Inventor Ji Yun YOO

Ji Yun YOO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF
    Publication number: 20250082762
    Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.
    Type: Application
    Filed: November 15, 2024
    Publication date: March 13, 2025
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, UBIX THERAPEUTICS, INC.
    Inventors: Pil Ho KIM, Sung Yun CHO, Jae Du HA, Chi Hoon PARK, Jong Yeon HWANG, Hyun Jin KIM, Song Hee LEE, Ye Seul LIM, Han Wool KIM, Sun Mi YOO, Beom Seon SUH, Ji Youn PARK, Je Ho RYU, Jung Min AHN, Hee Jung MOON, Ho Hyun LEE
  • BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF
    Publication number: 20250073341
    Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.
    Type: Application
    Filed: November 15, 2024
    Publication date: March 6, 2025
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, UBIX THERAPEUTICS, INC.
    Inventors: Pil Ho KIM, Sung Yun CHO, Jae Du HA, Chi Hoon PARK, Jong Yeon HWANG, Hyun Jin KIM, Song Hee LEE, Ye Seul LIM, Han Wool KIM, Sun Mi YOO, Beom Seon SUH, Ji Youn PARK, Je Ho RYU, Jung Min AHN, Hee Jung MOON, Ho Hyun LEE
  • Composition for skin whitening comprising ?-mangostin as effective ingredient
    Patent number: 11882858
    Abstract: A skin whitening composition includes ?-mangostin or a cosmetically acceptable salt thereof as an effective ingredient. ?-Mangostin represented by Chemical Formula 1 suppresses the expression of tyrosinase and TRP-1 (tyrosinase-related protein-1) and induces autophagy of a melasosome. As such, it was confirmed that the ?-mangostin not only suppresses melanin production but also exhibits the effect of removing previously formed melanin. Accordingly, the ?-mangostin can be advantageously used as a functional material for skin whitening and skin lightening.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: January 30, 2024
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
    Inventors: Kwang Dong Kim, Ji Yun Yoo, Hyung Won Ryu, Soojong Park, Kiwon Lee, Ki Hun Park, Sangseok Oh
  • Composition for skin whitening comprising amorphigeni as effective ingredient
    Patent number: 10500146
    Abstract: A skin whitening composition includes amorphigeni or a salt thereof as an effective ingredient. Amorphigeni suppresses the expression of tyrosinase and induces autophagy on melanosomes. As such, it was confirmed that amorphigeni not only suppresses melanin production but also exhibits the effect of removing melanin previously produced by ?-MSH (melanocyte-stimulating hormone). Accordingly, amorphigeni can be advantageously used as a functional material for skin whitening and skin lightening.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: December 10, 2019
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
    Inventors: Kwang Dong Kim, Ji Yun Yoo, Soojong Park, Sangseok Oh, Dae Wook Kim, Ki Hun Park, Kiwon Lee
  • COMPOSITION FOR SKIN WHITENING COMPRISING AMORPHIGENI AS EFFECTIVE INGREDIENT
    Publication number: 20180303734
    Abstract: A skin whitening composition includes amorphigeni or a salt thereof as an effective ingredient. Amorphigeni suppresses the expression of tyrosinase and induces autophagy on melanosomes. As such, it was confirmed that amorphigeni not only suppresses melanin production but also exhibits the effect of removing melanin previously produced by ?-MSH (melanocyte-stimulating hormone). Accordingly, amorphigeni can be advantageously used as a functional material for skin whitening and skin lightening.
    Type: Application
    Filed: October 13, 2016
    Publication date: October 25, 2018
    Inventors: Kwang Dong KIM, Ji Yun YOO, Soojong PARK, Sangseok OH, Dae Wook KIM, Ki Hun PARK, Kiwon LEE
  • COMPOSITION FOR SKIN WHITENING COMPRISING BETA-MANGOSTIN AS EFFECTIVE INGREDIENT
    Publication number: 20180256486
    Abstract: A skin whitening composition includes ?-mangostin or a cosmetically acceptable salt thereof as an effective ingredient. ?-Mangostin represented by Chemical Formula 1 suppresses the expression of tyrosinase and TRP-1 (tyrosinase-related protein-1) and induces autophagy of a melasosome. As such, it was confirmed that the ?-mangostin not only suppresses melanin production but also exhibits the effect of removing previously formed melanin. Accordingly, the ?-mangostin can be advantageously used as a functional material for skin whitening and skin lightening.
    Type: Application
    Filed: September 20, 2016
    Publication date: September 13, 2018
    Inventors: Kwang Dong KIM, Ji Yun YOO, Hyung Won RYU, Soojong PARK, Kiwon LEE, Ki Hun PARK, Sangseok OH